Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2239 (LINC02239) is a long non-coding RNA (lncRNA) gene located on chromosome 5 (24,835,280-24,840,583, reverse strand)[3][1][5]. As a member of the lncRNA class, LINC02239 does not encode a protein but may have regulatory roles at the RNA level. There is currently no evidence in the available literature that LINC02239 functions as a therapeutic target, receptor, or enzyme, nor is there evidence of its direct implication in specific biological pathways or diseases as a molecular target. It is listed in gene annotation resources, but its biological function, disease involvement, and potential as a biomarker or therapeutic target remain uncharacterized[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2239 (LINC02239).